Filter your results
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 CasesAmerican Journal of Kidney Diseases, 2014, 63 (1), pp.40-48. ⟨10.1053/j.ajkd.2013.07.011⟩
Journal articles
inserm-02162259v1
|
||
|
Severe Infection in Anti-Glomerular Basement Membrane Disease: A Retrospective Multicenter French StudyJournal of Clinical Medicine, 2020, 9 (3), pp.698. ⟨10.3390/jcm9030698⟩
Journal articles
hal-02796989v1
|
||
|
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab DiscontinuationClinical Journal of the American Society of Nephrology, 2017, 12 (1), pp.50-59. ⟨10.2215/CJN.06440616⟩
Journal articles
inserm-02155912v1
|
||
|
Protease resistance and binding of Ig light chains in myeloma-associated tubulopathiesKidney International, 1995, 48, pp.72 - 79. ⟨10.1038/ki.1995.269⟩
Journal articles
inserm-01876779v1
|